Literature DB >> 8137509

Alpha-skeletal actin is associated with increased contractility in the mouse heart.

T E Hewett1, I L Grupp, G Grupp, J Robbins.   

Abstract

BALB/c mice express abnormally high levels of alpha-skeletal actin in the heart, which may be related to a duplication in the promoter of the alpha-cardiac actin gene. To evaluate the effects of overexpression of the alpha-skeletal actin isoform on cardiac contractile function, we studied these mice using the isolated perfused work-performing murine heart model and measured actin isoform expression in the same hearts. We quantified myocardial contractility from the maximum rate of contraction (+dP/dt) and time to peak pressure and relaxation from -dP/dt and time to half relaxation of left intraventricular pressure. Dot blots of total RNA hybridized against oligonucleotide sequences specific for either alpha-skeletal or alpha-cardiac actin mRNA showed that increased levels of alpha-skeletal actin RNA correlated significantly with increased contractility of hearts from the BALB/c mice (r = .80, n = 15, P < .001). The present study demonstrates a significant functional correlation between alpha-actin isoform content and cardiac contractile function and also that alpha-skeletal actin may promote an increased contractile function in the heart compared with alpha-cardiac actin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137509     DOI: 10.1161/01.res.74.4.740

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  34 in total

Review 1.  Molecular and cellular mechanisms of myocardial remodeling.

Authors:  Melanie Maytin; Wilson S Colucci
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

2.  Elevated Ca2+ transients and increased myofibrillar power generation cause cardiac hypercontractility in a model of Noonan syndrome with multiple lentigines.

Authors:  Sarah A Clay; Timothy L Domeier; Laurin M Hanft; Kerry S McDonald; Maike Krenz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-27       Impact factor: 4.733

Review 3.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

4.  Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide receptor (GC-A) deficient mice.

Authors:  M Kuhn; R Holtwick; H A Baba; J C Perriard; W Schmitz; E Ehler
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

5.  Influence of genetic background on ex vivo and in vivo cardiac function in several commonly used inbred mouse strains.

Authors:  Matthew S Barnabei; Nathan J Palpant; Joseph M Metzger
Journal:  Physiol Genomics       Date:  2010-07-13       Impact factor: 3.107

6.  Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats.

Authors:  K Takeuchi; T Omura; M Yoshiyama; K Yoshida; R Otsuka; Y Shimada; K Ujino; J Yoshikawa
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

7.  New insights into the molecular phenotype of eccentric hypertrophy.

Authors:  Sebastiano Sciarretta; Junichi Sadoshima
Journal:  J Mol Cell Cardiol       Date:  2010-04-08       Impact factor: 5.000

8.  Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart.

Authors:  W K Jones; I L Grupp; T Doetschman; G Grupp; H Osinska; T E Hewett; G Boivin; J Gulick; W A Ng; J Robbins
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

9.  Context-dependent functional substitution of alpha-skeletal actin by gamma-cytoplasmic actin.

Authors:  Michele A Jaeger; Kevin J Sonnemann; Daniel P Fitzsimons; Kurt W Prins; James M Ervasti
Journal:  FASEB J       Date:  2009-03-11       Impact factor: 5.191

10.  Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin.

Authors:  Kristen J Nowak; Gianina Ravenscroft; Connie Jackaman; Aleksandra Filipovska; Stefan M Davies; Esther M Lim; Sarah E Squire; Allyson C Potter; Elizabeth Baker; Sophie Clément; Caroline A Sewry; Victoria Fabian; Kelly Crawford; James L Lessard; Lisa M Griffiths; John M Papadimitriou; Yun Shen; Grant Morahan; Anthony J Bakker; Kay E Davies; Nigel G Laing
Journal:  J Cell Biol       Date:  2009-05-25       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.